GIA
ABBV icon

Guyasuta Investment Advisors’s AbbVie ABBV Stock Holding History

Guyasuta Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.12M Buy
28,312
+131
+0.5% +$28.2K 0.37% 49
2026
Q1 		$6.13M Sell
28,181
-44
-0.2% -$9.76K 0.35% 46
2025
Q4 		$6.45M Buy
28,225
+1
+0% +$228 0.37% 48
2025
Q3 		$6.54M Sell
28,224
-1,181
-4% -$240K 0.38% 48
2025
Q2 		$5.46M Buy
29,405
+517
+2% +$96.1K 0.33% 50
2025
Q1 		$6.05M Sell
28,888
-1,489
-5% -$289K 0.4% 44
2024
Q4 		$5.4M Sell
30,377
-220
-0.7% -$40.4K 0.34% 50
2024
Q3 		$6.04M Sell
30,597
-659
-2% -$123K 0.37% 46
2024
Q2 		$4.84M Hold
31,256
– – 0.36% 47
2024
Q1 		$4.84M Hold
31,256
– – 0.35% 47
2023
Q4 		$4.84M Sell
31,256
-1,255
-4% -$183K 0.35% 47
2023
Q3 		$4.85M Buy
32,511
+774
+2% +$114K 0.38% 47
2023
Q2 		$4.28M Sell
31,737
-177
-0.6% -$26K 0.32% 49
2023
Q1 		$5.09M Sell
31,914
-153
-0.5% -$23.4K 0.39% 44
2022
Q4 		$5.18M Buy
32,067
+139
+0.4% +$21.3K 0.41% 46
2022
Q3 		$4.29M Buy
31,928
+90
+0.3% +$12.9K 0.37% 48
2022
Q2 		$4.88M Sell
31,838
-5,247
-14% -$802K 0.38% 49
2022
Q1 		$6.01M Sell
37,085
-789
-2% -$115K 0.41% 45
2021
Q4 		$5.13M Hold
37,874
– – 0.34% 53
2021
Q3 		$4.08M Buy
37,874
+1,912
+5% +$218K 0.29% 57
2021
Q2 		$4.05M Buy
35,962
+1,585
+5% +$179K 0.29% 56
2021
Q1 		$3.72M Buy
34,377
+443
+1% +$47.4K 0.29% 55
2020
Q4 		$3.64M Buy
33,934
+412
+1% +$39.6K 0.3% 51
2020
Q3 		$2.94M Buy
33,522
+2,985
+10% +$281K 0.27% 56
2020
Q2 		$3M Buy
30,537
+6,847
+29% +$603K 0.31% 52
2020
Q1 		$1.8M Buy
23,690
+1,556
+7% +$133K 0.22% 61
2019
Q4 		$1.96M Sell
22,134
-485
-2% -$40.3K 0.19% 70
2019
Q3 		$1.71M Hold
22,619
– – 0.18% 71
2019
Q2 		$1.65M Hold
22,619
– – 0.17% 74
2019
Q1 		$1.82M Hold
22,619
– – 0.2% 68
2018
Q4 		$2.08M Sell
22,619
-963
-4% -$84.7K 0.26% 54
2018
Q3 		$2.23M Sell
23,582
-525
-2% -$49.8K 0.24% 56
2018
Q2 		$2.23M Buy
24,107
+641
+3% +$62.6K 0.26% 53
2018
Q1 		$2.22M Buy
23,466
+1,437
+7% +$158K 0.26% 52
2017
Q4 		$2.13M Hold
22,029
– – 0.24% 57
2017
Q3 		$1.96M Hold
22,029
– – 0.24% 57
2017
Q2 		$1.6M Hold
22,029
– – 0.19% 64
2017
Q1 		$1.44M Sell
22,029
-265
-1% -$16.7K 0.17% 70
2016
Q4 		$1.4M Sell
22,294
-318
-1% -$19.4K 0.18% 68
2016
Q3 		$1.43M Sell
22,612
-1,575
-7% -$102K 0.18% 66
2016
Q2 		$1.5M Sell
24,187
-196,433
-89% -$12M 0.2% 62
2016
Q1 		$12.6M Buy
220,620
+3,684
+2% +$205K 1.75% 26
2015
Q4 		$12.9M Buy
216,936
+19,915
+10% +$1.15M 1.81% 26
2015
Q3 		$10.7M Buy
197,021
+10,429
+6% +$679K 1.56% 29
2015
Q2 		$12.5M Buy
186,592
+5,584
+3% +$365K 1.66% 31
2015
Q1 		$10.6M Buy
181,008
+138,015
+321% +$8.34M 1.42% 31
2014
Q4 		$2.81M Buy
42,993
+248
+0.6% +$15.6K 0.38% 40
2014
Q3 		$2.47M Buy
42,745
+1,690
+4% +$93.8K 0.34% 43
2014
Q2 		$2.32M Buy
41,055
+1,020
+3% +$53.5K 0.31% 48
2014
Q1 		$2.06M Buy
40,035
+875
+2% +$44.2K 0.29% 47
2013
Q4 		$2.07M Sell
39,160
-90
-0.2% -$4.42K 0.3% 48
2013
Q3 		$1.75M Buy
39,250
+750
+2% +$33.2K 0.28% 49
2013
Q2 		$1.59M Buy
+38,500
New +$1.68M 0.26% 52

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Guyasuta Investment Advisors's ABBV Position: Q2 2026 in Review

Guyasuta Investment Advisors increased its AbbVie (ABBV) stake by 0.46% in Q2 2026, buying an estimated $28.2K and bringing the position to 28,312 shares worth $7.12M. The position accounts for 0.37% of the portfolio, ranked #49.

Guyasuta Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.9M in Q4 2015. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Guyasuta Investment Advisors held 28,312 shares of AbbVie worth $7.12M as of Q2 2026.
  • Guyasuta Investment Advisors bought 131 AbbVie shares in Q2 2026, an estimated $28.2K.
  • AbbVie made up 0.37% of Guyasuta Investment Advisors's portfolio in Q2 2026, its #49 holding.
  • Guyasuta Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Guyasuta Investment Advisors's AbbVie position peaked at $12.9M in Q4 2015.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.